| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.005 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |